|
- Recor Medical - Homepage
Recor will unleash the power of ultrasound A high standard for lowering blood pressure Discover a sound approach to hypertension treatment
- Paradise Ultrasound RDN System - Recor Medical
Data on file Recor Medical; Anatomies may vary, see IFU Rader et al EuroIntervention 2022;18:e677-e685 Bloch et al AHA 2023 (n=49) Bloch et al TCT 2023 (n=64) V Zeijen, ACHIEVE Study update TCT 2023 (n=27) Open-label follow-up data (not part of PMA pivotal data) Kirtane et al JAMA Cardiol 2023;8 (5):464-473 Bloch et al Hypertens
- Press Releases - Recor Medical
Palo Alto, Calif – July 10, 2025 – Recor Medical, Inc (“Recor”) and its parent company, Otsuka Medical Devices Co , Ltd (“Otsuka Medical Devices”), today announced their support for the Centers for Medicare and Medicaid Services’ (CMS)
- Clinical Results Highlights - Recor Medical
Paradise Ultrasound Renal Denervation (uRDN) has been tested and proven effective across multiple clinical trials, including Recor’s RADIANCE™ global program and the ACHIEVE study
- Our Story - Recor Medical
Recor Medical was founded in 2009 with a singular focus: create a breakthrough therapy to treat hypertension using ultrasound technology We developed the Paradise™ Ultrasound Renal Denervation system and tested it over several years through the most rigorous randomized controlled trials
- Recor Medical – Ultrasound Denervation Product
Hear from patients about their experiences with high blood pressure and what led them to choose the Paradise procedure Patient Testimonial_David L from Recor Events on Vimeo
- Connect - Recor Medical
Connect with us and reach out if you need anything at all that Recor Medical can help with We are here to help
- Careers - Recor Medical
At Recor, you’ll join a team that values what makes you unique Our individual experiences, perspectives, talents and contributions are our greatest sources of strength, helping us to change peoples’ lives for the better
|
|
|